ChartMill assigns a Buy % Consensus number of 84% to TNYA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-12-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-10 | William Blair | Initiate | Outperform |
| 2024-05-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-20 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-30 | Leerink Partners | Initiate | Outperform |
15 analysts have analysed TNYA and the average price target is 10.35 USD. This implies a price increase of 1193.06% is expected in the next year compared to the current price of 0.8001.
The consensus rating for TENAYA THERAPEUTICS INC (TNYA) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.